{
  "resourceType" : "MedicinalProductDefinition",
  "id" : "Estalis-Transdermalpatch",
  "meta" : {
    "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Estalis-Transdermalpatch</b></p><a name=\"Estalis-Transdermalpatch\"> </a><a name=\"hcEstalis-Transdermalpatch\"> </a><a name=\"Estalis-Transdermalpatch-en-US\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-medicinalproductdefinition.html\">IDMP MedicinalProductDefinition</a></p></div><p><b>CH - SMC Authorized Dose Form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10519000}\">Transdermal patch</span></p><p><b>identifier</b>: <code>http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID</code>/CH-7601001029439-5470402</p><p><b>domain</b>: <span title=\"Codes:{http://spor.ema.europa.eu/v1/lists/100000000004 100000000012}\">Human</span></p><p><b>indication</b>: </p><div><p>Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}\">Medicinal product subject to medical or veterinary prescription (B)</span></p><p><b>additionalMonitoringIndicator</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator 756005001003}\">No Warning</span></p><p><b>pediatricUseIndicator</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator 756005003002}\">Not authorised for the treatment in children</span></p><p><b>classification</b>: <span title=\"Codes:{http://www.whocc.no/atc G03FA01}\">norethisterone and estrogen</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category 756005021001}\">NA KAS art. 12 para. 5 TPLO</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode 756005004001}\">Synthetic</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type 756001003002}\">Originator product</span></p><p><b>attachedDocument</b>: </p><ul><li><a href=\"DocumentReference-DocRef-FI-Estalis.html\">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-hij-123; status = current; type = Fachinformation; date = 2021-10-01 00:00:00+0000</a></li><li><a href=\"DocumentReference-DocRef-PI-Estalis.html\">DocumentReference: identifier = http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-AttachmentNumber#123456789-initial submission-Example-hij-321; status = current; type = Patienteninformation; date = 2021-10-01 00:00:00+0000</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: ESTALIS Matrixpfl 50/250 24 Stk</p><p><b>type</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}\">Zugelassener Arzneimittelname</span></p><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 CH}\">Switzerland</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 de-CH}\">German (Switzerland)</span></td></tr></table></blockquote></div>"
  },
  "extension" : [{
    "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "http://standardterms.edqm.eu",
        "code" : "10519000",
        "display" : "Transdermal patch"
      }]
    }
  }],
  "identifier" : [{
    "system" : "http://SMC.ch/ig/idmp/NamingSystem/IDSystem-ch-MPID",
    "value" : "CH-7601001029439-5470402"
  }],
  "domain" : {
    "coding" : [{
      "system" : "http://spor.ema.europa.eu/v1/lists/100000000004",
      "code" : "100000000012",
      "display" : "Human"
    }]
  },
  "indication" : "Klimakterische Beschwerden: Behandlung der Symptome des Östrogenmangels infolge der natürlichen oder künstlichen Menopause bei nicht-hysterektomierten Frauen.\nOsteoporoseprophylaxe: Vorbeugung oder Verzögerung einer durch Östrogenmangel induzierten Osteoporose bei postmenopausalen Frauen mit hohem Frakturrisiko, für die eine Behandlung mit anderen zur Prävention der Osteoporose zugelassenen Arzneimitteln nicht in Frage kommt, oder bei Frauen die gleichzeitig an behandlungsbedürftigen Symptomen des Östrogenmangels leiden.",
  "legalStatusOfSupply" : {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply",
      "code" : "756005022003",
      "display" : "Medicinal product subject to medical or veterinary prescription (B)"
    }]
  },
  "additionalMonitoringIndicator" : {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator",
      "code" : "756005001003",
      "display" : "No Warning"
    }]
  },
  "pediatricUseIndicator" : {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator",
      "code" : "756005003002",
      "display" : "Not authorised for the treatment in children"
    }]
  },
  "classification" : [{
    "coding" : [{
      "system" : "http://www.whocc.no/atc",
      "code" : "G03FA01"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category",
      "code" : "756005021001",
      "display" : "NA KAS art. 12 para. 5 TPLO"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode",
      "code" : "756005004001",
      "display" : "Synthetic"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type",
      "code" : "756001003002",
      "display" : "Originator product"
    }]
  }],
  "attachedDocument" : [{
    "reference" : "DocumentReference/DocRef-FI-Estalis"
  },
  {
    "reference" : "DocumentReference/DocRef-PI-Estalis"
  }],
  "name" : [{
    "productName" : "ESTALIS Matrixpfl 50/250 24 Stk",
    "type" : {
      "coding" : [{
        "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type",
        "code" : "SMC",
        "display" : "Zugelassener Arzneimittelname"
      }]
    },
    "usage" : [{
      "country" : {
        "coding" : [{
          "system" : "urn:iso:std:iso:3166",
          "code" : "CH",
          "display" : "Switzerland"
        }]
      },
      "language" : {
        "coding" : [{
          "system" : "urn:ietf:bcp:47",
          "code" : "de-CH",
          "display" : "German (Switzerland)"
        }]
      }
    }]
  }]
}